Validity and acceptability of a French-language version of the Brief Edinburgh Depression Scale

摘要

Introduction: Depression is a frequent symptom among cancer patients but is rarely identified. The BriefnEdinburgh Depression Scale (BEDS) is widely used within the United Kingdom to screen for depressionnamong patients with advanced cancer, but its use elsewhere is limited by the lack of appropriatentranslations. We translated the BEDS into French and then validated the translated version with andnassessed its acceptability by cancer patients in France.nMethods: We used back-to-back translation and standard European Organization for Research andnTreatment of Cancer procedures to translate the BEDS into French. The French version was validatednagainst Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) semi-structured psychiatricninterviews with 48 patients with advanced cancer who were admitted to a palliative care unit. Acceptabilitynwas determined with these inpatients and with 95 outpatients at a Comprehensive Cancer Center.nResults: Among inpatients, the prevalence of major depressive disorder according to the psychiatricninterview was 56.3% and the optimum cut-off of the BEDS score was >6, which yielded a sensitivity ofn82.8% and a specificity of 68.4%. Among outpatients, the prevalence of probable depression (BEDSnscore >6) was 28%. All inpatients (100%) and all but six outpatients (95%) completed the BEDS survey.nConclusion: The French-language BEDS is a valid and sensitive tool for screening in the case of depressionnand it is applicable to cancer patients.